Lataa...
177Lu-DOTATATE and 177Lu-prostate-specific membrane antigen therapy in a patient with advanced metastatic radioiodine-refractory differentiated thyroid cancer after failure of tyrosine kinase inhibitors treatment
Patients with radioiodine-refractory differentiated thyroid cancer (RrDTC) have only a limited or no benefit from radioiodine therapy. For these patients, tyrosine kinase inhibitors have demonstrated encouraging results in advanced RrDTC. Nevertheless, these therapies are related with substantial si...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2019-10-01
|
| Sarja: | World Journal of Nuclear Medicine |
| Aiheet: | |
| Linkit: | http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_112_18 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|